Aucubin promotes angiogenesis via estrogen receptor beta in a mouse model of hindlimb ischemia

Publication date: Available online 12 July 2017
Source:The Journal of Steroid Biochemistry and Molecular Biology
Author(s): Lu Chen, Yue Yang, Lusha Zhang, Chunxiao Li, Joel Wake Coffie, Xiao Geng, Lizhen Qiu, Xingyu You, Zhirui Fang, Min Song, Xiumei Gao, Hong Wang
Aucubin (AU) is an iridoid glycoside that has been shown to display estrogenic properties and has various pharmacological effects. Herein, we described the angiogenic properties of AU. In the study, hindlimb ischemia was induced by ligation of femoral artery on the right leg of ovariectomized mice. AU treatment significantly accelerated perfusion recovery and reduced tissue injury in mice muscle. Quantification of CD31-positive vessels in hindlimb muscles provided evidences that AU promoted angiogenesis in peripheral ischemia. In addition, results from quantitative PCR and western blot suggested AU induced angiogenesis via vascular endothelial cell growth factor (VEGF)/Akt/endothelial nitric oxide synthase (eNOS) signaling pathway. More interestingly, AU's angiogenic effects could be completely abolished in estrogen receptor beta (ERβ) knockout mice. In conclusion, the underlying mechanisms were elucidated that AU produced pro-angiogenic effects through ERβ-mediated VEGF signaling pathways. These results expand knowledge about the beneficial effects of AU in angiogenesis and blood flow recovery. It might provide insight into the ERβ regulating neovascularisation in hindlimb ischemia and identify AU as a potent new compound used for the treatment of peripheral vascular disease.

Graphical abstract

http://ift.tt/2tL5FQI